4//SEC Filing
Mertz Larry Michael 4
Accession 0001628280-23-019635
CIK 0000727207other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 8:03 PM ET
Size
26.2 KB
Accession
0001628280-23-019635
Insider Transaction Report
Form 4
Mertz Larry Michael
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2023-05-22+10,000→ 526,339 total - Exercise/Conversion
Common Stock
2023-05-22+2,836→ 526,464 total - Sale
Common Stock
2023-05-22$0.72/sh−2,711$1,952→ 523,628 total - Exercise/Conversion
Employee Restricted Stock Units
2023-05-22−2,836→ 2,835 total→ Common Stock (2,836 underlying) - Exercise/Conversion
Employee Restricted Stock Units
2023-05-22−10,000→ 10,000 total→ Common Stock (10,000 underlying) - Sale
Common Stock
2023-05-22$0.72/sh−769$554→ 525,695 total
Footnotes (3)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 30,000 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Common Stock for each RSU. On May 20, 2021, the reporting person was granted a total of 8,507 restricted stock units, which vests in equal amounts every year over three years, which started vesting on May 20, 2022.
Issuer
Accelerate Diagnostics, Inc
CIK 0000727207
Entity typeother
Related Parties
1- filerCIK 0001938051
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 8:03 PM ET
- Size
- 26.2 KB